Allelotyping in mycosis fungoides and Sézary syndrome: common regions of allelic loss identified on 9p, 10q, and 17p.
Allelotyping studies have been extensively used in a wide variety of malignancies to define chromosomal regions of allelic loss and sites of putative tumor suppressor genes; however, until now this technique has not been used in cutaneous lymphoma. We have analyzed 51 samples from patients with mycosis fungoides and 15 with Sézary syndrome using methods to detect loss of heterozygosity. Micro satellite markers were selected on 15 chromosomal arms because of their proximity to either known tumor suppressor genes or chromosomal abnormalities identified in previous cytogenetic studies in cutaneous lymphoma. Allelic loss was present in 45% of patients with mycosis fungoides and 67% with Sézary syndrome. Loss of heterozygosity was found in over 10% of patients with mycosis fungoides on 9p, 10q, 1p, and 17p and was present in 37% with early stage (T1 and T2) and 57% with advanced disease (T3 and T4). Allelic loss on 1p and 9p were found in all stages of mycosis fungoides, whereas losses on 17p and 10q were limited to advanced disease. In Sézary syndrome high rates of loss of heterozygosity were detected on 9p (46%) and 17p (42%) with lower rates on 2p (12%), 6q (7%), and 10q (12%). There was no significant difference in the age at diagnosis or number of treatments received by those with loss of heterozygosity and those without, suggesting that increasing age and multiple treatments do not predispose to allelic loss. These results provide the basis for further studies defining more accurately chromosomal regions of deletions and candidate tumor suppressor genes involved in mycosis fungoides and Sézary syndrome.
Scarisbrick
J J
JJ
Skin Tumour Unit, St John's Institute Dermatology, St Thomas' Hospital, London, UK. juliascarisbrick@doctors.org.uk
Woolford
A J
AJ
Russell-Jones
R
R
Whittaker
S J
SJ
D002879:Chromosomes, Human, Pair 10; D002886:Chromosomes, Human, Pair 17; D002899:Chromosomes, Human, Pair 9; D005819:Genetic Markers; D006801:Humans; D019656:Loss of Heterozygosity; D008875:Middle Aged; D009182:Mycosis Fungoides / Q000235:genetics* / Q000401:mortality; D012751:Sezary Syndrome / Q000235:genetics* / Q000401:mortality; D012878:Skin Neoplasms / Q000235:genetics* / Q000401:mortality; D016019:Survival Analysis
D005819:Genetic Markers